On August 27, 2025, the FDA approved the first generic version of liraglutide (Saxenda) for weight loss in adults and adolescents with obesity and adults with overweight and at least one weight-related comorbid condition
Discussion Reagents that promote -cell proliferation are potentially very important as treatment modalities for diabetes mellitus
As its use has expanded, questions have emerged regarding potential links between Ozempic and mental health changes, particularly depression
However, prospective studies are required to determine whether vitamin D supplementation can enhance the metabolic efficacy of GLP-1 receptor agonists
Exercise and activity Exercise is not required for weight loss on tirzepatide, but it dramatically improves body composition outcomes
This is where Coenzyme Q10 (CoQ10) , a fat-soluble, vitamin-like compound, plays an indispensable role